Doxorubicin Completed Phase 1 Trials for Soft Tissue Sarcoma (STS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03283696A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
NCT02783599A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
NCT00502411Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma